3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 7.63
-0.30 (-3.78%)
Sep 5, 2025, 4:08 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 1.87 billion as of September 5, 2025. Its market cap has increased by 95.08% in one year.
Market Cap
1.87B
Enterprise Value
1.47B
Revenue
491.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.63
Market Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 1.87B, a decrease of -73.39%. That is a compound annual growth rate of -38.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 1.87B | 147.65% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 288.59B |
| Hansoh Pharmaceutical Group Company | 214.91B |
| JD Health International | 206.17B |
| Innovent Biologics | 183.26B |
| Sino Biopharmaceutical | 150.05B |
| WuXi Biologics | 148.90B |
| Akeso | 132.13B |
| CSPC Pharmaceutical Group | 123.82B |